Apellis Pharmaceuticals, Inc. ($APLS)
DeLong Mark Jeffrey โ Chief Business & Strat Officer
Shares
368
Price
$22.15
Total Value
$8,152.56
Nearby Earnings
Feb 24, 2026
EPS:Est: -0.39
Revenue:Est: $199.28M
Transaction Details
| Insider | DeLong Mark Jeffrey |
|---|---|
| Title | Chief Business & Strat Officer |
| Transaction Date | Feb 11, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Feb 13, 2026 |
| Document Date | Feb 11, 2026 |
| Shares Sold | 368 |
| Price per Share | $22.15 |
| Total Value | $8,152.56 |
| Shares Owned After | 114,591 |
| Derivative | No |
| Accession Number | 0001492422-26-000083 |
| Document | View SEC Filing |